{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T13:36:40Z","timestamp":1648820200470},"reference-count":4,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,13]]},"DOI":"10.1093\/cid\/ciy436","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T15:13:18Z","timestamp":1526483598000},"page":"1797-1798","source":"Crossref","is-referenced-by-count":0,"title":["Pregnancy Screening and Monitoring of Albendazole Therapy for Neurocysticercosis"],"prefix":"10.1093","volume":"67","author":[{"given":"Jon G","family":"Persichino","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loren G","family":"Miller","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, California"},{"name":"Division of Infectious Diseases, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"key":"key\n\t\t\t\t2018111310163832100_CIT0001","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/cid\/ciy157","article-title":"Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"66","author":"White","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2018111310163832100_CIT0002","volume-title":"Prescribing information: albendazole","author":"US Food and Drug Administration"},{"key":"key\n\t\t\t\t2018111310163832100_CIT0003","first-page":"CD005547","article-title":"Effect of administration of anthelminthics for soil transmitted helminths during pregnancy","volume":"6","author":"Salam","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2018111310163832100_CIT0004","volume-title":"Prescribing information: methotrexate","author":"US Food and Drug Administration"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/67\/11\/1797\/26555071\/ciy436.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T23:58:21Z","timestamp":1571356701000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/67\/11\/1797\/5001406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":4,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,5,22]]},"published-print":{"date-parts":[[2018,11,13]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy436","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12,1]]},"published":{"date-parts":[[2018,5,22]]}}}